25
Participants
Start Date
March 1, 2024
Primary Completion Date
March 1, 2029
Study Completion Date
March 1, 2029
High-dose chemotherapy (TI- 2 cycles, CE- 3 cycles )
"TI: Paclitaxel 200mg/m² on day 1, Ifosfamide 2000mg/m² daily from days 1 to 3 of 14-day cycle. G-CSF 10 micrograms/Kg SC daily day on days 6-14 day or until CD34 harvest. Leukapheresis will be performed starting on day 11 in case blood level of CD45+CD34+ above 20x10\^6/L is achieved.~CE: Carboplatin AUC=8 IV daily days -4 to -2, Etoposide 400mg/m\^2 IV daily days -4 to -2, autlologous stemm cell transplantation \>=2\*10\^6/Kg at day 0, GCSF support from day 4 until the recovery of neutrophils above 1\*10\^9/L.~Patients will receive two cycles of TI followed by 3 cycles of CE in case at least 6\*10\^6 CD34+ stem cells will be harvested."
RECRUITING
National Medical Research Center of Oncology named after N.N.Petrov Ministry of health of Russia, Saint Petersburg
N.N. Petrov National Medical Research Center of Oncology
OTHER